Results 261 to 270 of about 67,462 (301)
Some of the next articles are maybe not open access.
Pediatric Ventricular Assist Devices
Pediatric Cardiology, 2007Ventricular assist device therapy is continuing to evolve in the practice of pediatric cardiac surgery. Although ECMO is still the most often applied mechanical support for infants and young children, a broader range of pulsatile, paracorporeal, as well as implantable ventricular assist devices are now available for pediatric application.
Francis, Fynn-Thompson +1 more
openaire +2 more sources
Left ventricular assist devices
Heart, 2009Left ventricular assist device (LVAD) insertion in patients with advanced heart failure with deteriorating clinical status is life saving, and LVADs are now being inserted into an increasing number of patients with advanced heart failure. They were initially inserted as a bridge to transplantation, and the decreased availability of donor hearts means ...
openaire +2 more sources
Demystifying Ventricular Assist Devices
Critical Care Nursing Quarterly, 2011Many people throughout the world are living with heart disease and advanced heart failure. They may be in need of a heart transplant, but because of the limited amount of donor hearts available, other options need to be available. Because of the advancement of technology, there are now other options, and one option available would be a mechanical ...
openaire +2 more sources
Ventricular Assist Device Infections
Cardiology Clinics, 2018This article reviews the diagnostic criteria for ventricular assist device (VAD) infection, pathogenesis, and microbiology as well as the diagnostic pathway when patients present with signs and symptoms concerning for VAD infection. Recommendations regarding infection prevention and management are reviewed as well.
openaire +2 more sources
Centrifugal Ventricular Assist Devices
AACN Advanced Critical Care, 1991A centrifugal ventricular assist device (VAD) uses centrifugal force to propel blood through nonocclusive pumpheads. Blood is diverted from either the right atrium or left atrium to a disposable pumphead. Then kinetic energy is added to blood contained within the VAD by rotating it at high speed.
openaire +2 more sources
2018
Abstract Ventricular assist devices (VADs) have become a cornerstone of therapy in the management of end-stage heart failure, both as a means of bridging to cardiac transplantation and as destination therapy for long-term quality of life improvement.
Rajagopala Padmanabhan, Penny Sappington
openaire +2 more sources
Abstract Ventricular assist devices (VADs) have become a cornerstone of therapy in the management of end-stage heart failure, both as a means of bridging to cardiac transplantation and as destination therapy for long-term quality of life improvement.
Rajagopala Padmanabhan, Penny Sappington
openaire +2 more sources
1995
Extracardiac blood pumps may be used to allow temporary circulatory support in circumstances in which the pumping function of the heart is inadequate. Because of the complexity of these devices, the complications associated with their use, and cost considerations, all pharmacologic avenues of myocardial and circulatory support, as well as the ...
Bradley L. Bufkin, Robert A. Guyton
openaire +1 more source
Extracardiac blood pumps may be used to allow temporary circulatory support in circumstances in which the pumping function of the heart is inadequate. Because of the complexity of these devices, the complications associated with their use, and cost considerations, all pharmacologic avenues of myocardial and circulatory support, as well as the ...
Bradley L. Bufkin, Robert A. Guyton
openaire +1 more source
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
Kyobu geka. The Japanese journal of thoracic surgery, 2010
There are 2 kinds of artificial heart used for clinical patients with end-stage heart failure. One is a ventricular assist device (VAD) and the other is a total artificial heart (TAH). Only paracorporeal VADs are commercially available currently in Japan, such as Toyobo VAD and BVS 5000. Paracorporeal Zeon VAD and implantable Novacor LVAD were approved
Shunei, Kyo, S, Takamoto
openaire +1 more source
There are 2 kinds of artificial heart used for clinical patients with end-stage heart failure. One is a ventricular assist device (VAD) and the other is a total artificial heart (TAH). Only paracorporeal VADs are commercially available currently in Japan, such as Toyobo VAD and BVS 5000. Paracorporeal Zeon VAD and implantable Novacor LVAD were approved
Shunei, Kyo, S, Takamoto
openaire +1 more source